Antibiotics and bacteria: the laboratory finding, the production patent and the certified batch
Antibiotics and bacteria were linked in laboratory observations before penicillin could be manufactured reliably in large quantities. Antibiotics act against bacterial infections by killing bacteria or inhibiting their growth; they do not act against viruses. MedlinePlus uses that distinction in its definition of the medicines. Penicillin's development adds a historical dimension: recognizing antibacterial activity was only the beginning. Records of subsequent work include a production patent, FDA's wartime batch testing and a 1945 law requiring certification. Each concerned a different obstacle between observing an effect and distributing a medicine of dependable quality.
The American Chemical Society's history of penicillin describes Alexander Fleming's observation of bacterial colonies near a contaminating mold in 1928. His subsequent work identified activity against several kinds of harmful bacteria, but isolating a stable, pure substance remained difficult. Assistants Stuart Craddock and Frederick Ridley worked on that problem. Fleming published his findings in June 1929. At that stage, one practical use was separating bacteria sensitive to penicillin from organisms that were not sensitive in mixed cultures. The observed selectivity was useful in a laboratory even before the material could become a widely available medicine.
Later development required concentrated research on extraction, testing and supply. ACS describes the Oxford work led by Howard Florey, with Ernst Chain and colleagues, and the eventual cooperation with American laboratories and manufacturers. The historical sequence separates an initial observation from the work needed to turn it into a usable drug. Penicillin's antibacterial activity was a property of the material; dependable manufacture required control of the process producing that material. The development of antibiotics and bacteria research therefore involved chemists, microbiologists and production specialists, as well as the original investigator whose name became attached to the discovery.
An original production document survives as US patent 2,442,141, Method for Production of Penicillin. It names Andrew J. Moyer as inventor and the United States Department of Agriculture as assignee. The application was filed on 11 May 1945 and the patent issued on 25 May 1948. Its opening description identifies penicillin as bactericidal or bacteriostatic, meaning capable of killing bacteria or inhibiting their growth. The document's concern was increasing output and maintaining the penicillin content of culture liquid. It consequently records a manufacturing problem that remained distinct from the original observation of inhibited bacterial colonies.
The patent also shows the vocabulary used to evaluate a product whose chemistry was still being worked out. Its text described the Oxford unit as the available means of evaluating penicillin and stated that the chemical structure was unknown in the context it described. That statement belongs to the document's historical development setting, rather than to modern chemical knowledge. The patent's technical claims concerned a production method. They did not establish which illness any individual patient had, or make every infection susceptible to the resulting drug. Their scope lay in producing the antibacterial substance more efficiently and consistently.
FDA's museum history records what happened to manufactured lots before wartime distribution. After the Oxford group sought American assistance in 1941, government and private efforts expanded production; penicillin reached battlefields by 1943. War planning officials asked FDA to certify every lot before release to troops. The agency examined potency, toxicity, sterility, moisture and the absence of fever-producing contaminants. These checks concerned features of the finished medicine that an observation in a bacterial culture could not settle. Greater supply would have been insufficient without measurements of whether distributed material had dependable strength and acceptable quality.
Congress placed that certification work into statute on 6 July 1945. The original law, preserved in the Statutes at Large, amended the Federal Food, Drug, and Cosmetic Act to cover batches containing penicillin or its derivatives. It provided for certification based on identity, strength, quality and purity sufficient to ensure safety and effectiveness. It also linked labeling requirements to an effective batch certificate or release, with specified exemptions governed by regulations. The law covered drugs composed wholly or partly of penicillin. Its certification provisions therefore followed the substance across different formulations, with the named quality characteristics determining whether a batch qualified, rather than a particular brand name. This was a legal framework for evaluating batches. It transformed wartime administrative practice into an explicit statutory responsibility, rather than merely celebrating a scientific discovery.
The distinction between antibiotics and bacteria remained narrower than the broad idea of a medicine against infection. MedlinePlus specifies that antibiotics act on certain bacterial infections and do not work on viral infections. It also describes resistance as a change in bacteria that allows them to withstand a drug, reducing the medicine's effectiveness. The historical documents address complementary aspects of that relationship: selective antibacterial activity, industrial production and the quality of individual batches. None treats infection as one interchangeable category. Penicillin's route from laboratory observation to certified supply depended on identifying what the substance affected and measuring what manufacturers actually produced.
- MedlinePlus, Antibiotics: bacterial targets, viruses and resistance — medlineplus.gov
- American Chemical Society, Discovery and Development of Penicillin: National Historic Chemical Landmark — www.acs.org
- Andrew J. Moyer, US2442141A, Method for Production of Penicillin, filed 1945; issued 1948 — patents.google.com
- FDA museum, Drug Therapeutics & Regulation in the U.S.: penicillin and wartime batch certification — www.fda.gov
- United States Statutes at Large, 59 Stat. 463: Penicillin Amendment, 6 July 1945 — www.govinfo.gov